Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anika Therapeutics, Inc.ANIK · Entity 6005 | Director | January 24, 2018 | January 26, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anika Therapeutics, Inc.
Report date January 24, 2018 · Filed January 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,126 |
Reported balance
After 2016-12-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-22 · Other · Disposed 1,955 · Balance 34,126 F1: The total number of shares beneficially owned by the reporting person was incorrectly stated in Column 5 of the Form 4 filed by the reporting person on January 31, 2017. That total share number included these 1,955 shares, which were transferred on December 22, 2016 pursuant to a settlement agreement effective June 12, 2014. |
| Common StockSEC Table I · non-derivative | Direct | 32,968 |
Reported balance
After 2017-02-16 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2017-02-16 · Other · Disposed 1,158 · Balance 32,968 F2: These shares were transferred on February 16, 2017 pursuant to a settlement agreement effective June 12, 2014. |
| Common StockSEC Table I · non-derivative | Direct | 34,594 |
Reported balance
After 2018-01-24 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-01-24 · Grant · Acquired 1,626 · Balance 34,594 F3: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The total number of shares beneficially owned by the reporting person was incorrectly stated in Column 5 of the Form 4 filed by the reporting person on January 31, 2017. That total share number included these 1,955 shares, which were transferred on December 22, 2016 pursuant to a settlement agreement effective June 12, 2014.
F2: These shares were transferred on February 16, 2017 pursuant to a settlement agreement effective June 12, 2014.
F3: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HFF, Inc.
Report date July 01, 2019 · Filed July 01, 2019
Section 16 reporting ended · disclosed 2019-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-07-01 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2019-07-01 · Disposition to issuer · Disposed 32,802 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of March 18, 2019 (the "Merger Agreement"), between HFF, Inc. (the "Company"), Jones Lang LaSalle Incorporated ("JLL"), JLL CM, Inc. and JLL CMG, LLC. Pursuant to the Merger Agreement, in exchange for each share of Company common stock, the reporting person received (i) $24.63 in cash, without interest and subject to any required withholding taxes, and (ii) 0.1505 of a share of JLL common stock, par value $0.01 per share. Each disposition reported in this Form 4 is an exempt transaction. |
| Class A common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-07-01 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-07-01 · Disposition to issuer · Disposed 1,939 · Balance 0 F2: Disposed of pursuant to the Merger Agreement, between the Company, JLL, JLL CM, Inc. and JLL CMG, LLC. Pursuant to the Merger Agreement, in exchange for each share of Company restricted stock unit, the reporting person received an award of restricted stock units with respect to JLL common stock equal to the product of (i) the total number of shares of HFF common stock covered by the reporting person's Company restricted stock units multiplied by (ii) 0.301. Each disposition reported in this Form 4 is an exempt transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of March 18, 2019 (the "Merger Agreement"), between HFF, Inc. (the "Company"), Jones Lang LaSalle Incorporated ("JLL"), JLL CM, Inc. and JLL CMG, LLC. Pursuant to the Merger Agreement, in exchange for each share of Company common stock, the reporting person received (i) $24.63 in cash, without interest and subject to any required withholding taxes, and (ii) 0.1505 of a share of JLL common stock, par value $0.01 per share. Each disposition reported in this Form 4 is an exempt transaction.
F2: Disposed of pursuant to the Merger Agreement, between the Company, JLL, JLL CM, Inc. and JLL CMG, LLC. Pursuant to the Merger Agreement, in exchange for each share of Company restricted stock unit, the reporting person received an award of restricted stock units with respect to JLL common stock equal to the product of (i) the total number of shares of HFF common stock covered by the reporting person's Company restricted stock units multiplied by (ii) 0.301. Each disposition reported in this Form 4 is an exempt transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2019 Filed Jul 1, 2019 18:03 UTC | HFF, Inc. HF · Entity 156327 | Disposition to issuerClass A common stock | 1,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-039813 · doc4.xml · nonDerivative · entry 2 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Disposed of pursuant to the Merger Agreement, between the Company, JLL, JLL CM, Inc. and JLL CMG, LLC. Pursuant to the Merger Agreement, in exchange for each share of Company restricted stock unit, the reporting person received an award of restricted stock units with respect to JLL common stock equal to the product of (i) the total number of shares of HFF common stock covered by the reporting person's Company restricted stock units multiplied by (ii) 0.301. Each disposition reported in this Form 4 is an exempt transaction. Read SEC document |
| July 01, 2019 Filed Jul 1, 2019 18:03 UTC | HFF, Inc. HF · Entity 156327 | Disposition to issuerClass A common stock | 32,802 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-039813 · doc4.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of March 18, 2019 (the "Merger Agreement"), between HFF, Inc. (the "Company"), Jones Lang LaSalle Incorporated ("JLL"), JLL CM, Inc. and JLL CMG, LLC. Pursuant to the Merger Agreement, in exchange for each share of Company common stock, the reporting person received (i) $24.63 in cash, without interest and subject to any required withholding taxes, and (ii) 0.1505 of a share of JLL common stock, par value $0.01 per share. Each disposition reported in this Form 4 is an exempt transaction. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:12 UTC | HFF, Inc. HF · Entity 156327 | Exercise / conversionStock Option · Derivative | 6,494 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001209191-19-034228 · doc4.xml · derivative · entry 2 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Shares of Class A Common Stock, par value $.01 per share · 6,494 shares Expires 2020-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:12 UTC | HFF, Inc. HF · Entity 156327 | Exercise / conversionClass A Common Stock | 6,494 | $7.14 | $46,367.16 |
DisclosureSEC source: 0001209191-19-034228 · doc4.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2019 Filed May 28, 2019 15:19 UTC | HFF, Inc. HF · Entity 156327 | GrantClass A common stock | 1,939 | $43.84 | $85,005.76 |
DisclosureSEC source: 0001209191-19-032947 · doc4.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,247 F1 · shares: Shares are restricted stock units (RSUs) that will be distributed in three equal annual installments beginning on May 23, 2020, unless the reporting person elects to defer distribution pursuant to the Company's Deferred Compensation Plan. The RSUs were fully vested on the grant date. F2 · balance_after: On February 1, 2019, the Company declared a dividend, payable to all holders of record of Class A common stock on February 11, 2019, of $1.75 for each share of Class A common stock outstanding. Pursuant to the terms of the Company's 2016 Equity Incentive Plan and the outstanding grants of restricted stock units (RSUs) of Class A common stock, any RSUs of Class A common stock that were unvested (or vested but not settled) as of the dividend record date were entitled, in lieu of any cash dividend, to a stock dividend for each unvested (or vested but not settled) RSU of Class A common stock equal to the per-share cash dividend amount divided by the fair market value of a share of Class A common stock on the dividend date. As a result, as of February 27, 2019, the reporting person received 784 additional RSUs of Class A common stock, subject to the vesting and distribution requirements of the underlying RSUs held by the reporting person. Read SEC document |
| May 24, 2018 Filed May 29, 2018 13:17 UTC | HFF, Inc. HF · Entity 156327 | GrantClass A common stock | 2,410 | $35.27 | $85,000.70 |
DisclosureSEC source: 0001209191-18-033711 · doc4.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,524 F1 · shares: Shares are restricted stock units (RSUs) that will be distributed in three equal annual installments beginning on May 24, 2019, unless the reporting person elects to defer distribution pursuant to the Company's Deferred Compensation Plan. The RSUs were fully vested on the grant date. F2 · balance_after: On January 26, 2018, the Company declared a dividend, payable to all holders of record of Class A common stock on February 9, 2018, of $1.75 for each share of Class A common stock outstanding. Pursuant to the terms of the Company's 2016 Equity Incentive Plan and the outstanding grants of restricted stock units (RSUs) of Class A common stock, any RSUs of Class A common stock that were unvested (or vested but not settled) as of the dividend record date were entitled, in lieu of any cash dividend, to a stock dividend for each unvested (or vested but not settled) RSU of Class A common stock equal to the per-share cash dividend amount divided by the fair market value of a share of Class A common stock on the dividend date. As a result, as of February 21, 2018, the reporting person received 665 additional RSUs of Class A common stock, subject to the vesting and distribution requirements of the underlying RSUs held by the reporting person. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:12 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-18-000697 · form4wheeler.xml · nonDerivative · entry 3 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,594 F3 · security: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019. Read SEC document |
| May 25, 2017 Filed May 30, 2017 17:10 UTC | HFF, Inc. HF · Entity 156327 | GrantClass A common stock | 2,433 | $30.82 | $74,985.06 |
DisclosureSEC source: 0001209191-17-036167 · doc4.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,449 F1 · shares: Shares are restricted stock units (RSUs) that will be distributed in three equal annual installments beginning on May 25, 2018, unless the reporting person elects to defer distribution pursuant to the Company's Deferred Compensation Plan. The RSUs were fully vested on the grant date. F2 · balance_after: On January 24, 2017, the Company declared a dividend, payable to all holders of record of Class A common stock on February 9, 2016, of $1.57 for each share of Class A common stock outstanding. Pursuant to the terms of the Company's 2016 Equity Incentive Plan and the outstanding grants of restricted stock units (RSUs) of Class A common stock, any RSUs of Class A common stock that were unvested (or vested but not settled) as of the dividend record date were entitled, in lieu of any cash dividend, to a stock dividend for each unvested (or vested but not settled) RSU of Class A common stock equal to the per-share cash dividend amount divided by the fair market value of a share of Class A common stock on the dividend date. As a result, as of February 21, 2017, the reporting person received 768 additional RSUs of Class A common stock, subject to the vesting and distribution requirements of the underlying RSUs held by the reporting person. Read SEC document |
| February 16, 2017 Filed Jan 26, 2018 21:12 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | OtherCommon Stock | 1,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-18-000697 · form4wheeler.xml · nonDerivative · entry 2 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,968 F2 · security: These shares were transferred on February 16, 2017 pursuant to a settlement agreement effective June 12, 2014. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:14 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 1,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-000592 · formfour.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,081 F1 · security: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 27, 2018. Read SEC document |
| December 22, 2016 Filed Jan 26, 2018 21:12 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | OtherCommon Stock | 1,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-18-000697 · form4wheeler.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,126 F1 · security: The total number of shares beneficially owned by the reporting person was incorrectly stated in Column 5 of the Form 4 filed by the reporting person on January 31, 2017. That total share number included these 1,955 shares, which were transferred on December 22, 2016 pursuant to a settlement agreement effective June 12, 2014. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:05 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionStock Appreciation Right · Derivative | 1,090 | $0.00 Strike: $12.36 | $0.00 |
DisclosureSEC source: 0001171843-16-012958 · f4_wheeler110316.xml · derivative · entry 2 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. F1 · derivative.expiration_date: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:05 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionCommon Stock | 1,090 | $12.36 | $13,472.40 |
DisclosureSEC source: 0001171843-16-012958 · f4_wheeler110316.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. Read SEC document |
| March 04, 2010 Filed Jun 4, 2019 16:08 UTC Amendment | HFF, Inc. HF · Entity 156327 | GrantStock Option · Derivative | 6,494 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001209191-19-034220 · doc4a.xml · derivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,494 Underlying: Shares of Class A Common Stock, par value $.01 per share · 6,494 shares Expires 2010-03-04 F1 · derivative.exercise_price: This is to amend the Form 4 filed on March 5, 2010. An incorrect Conversion or Exercise Price of Derivative Security was reported. F2 · derivative.exercise_date: This stock option vested in three equal annual installments beginning on March 4, 2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.